Saturday, 10 November 2018

InfantRespiratory distress syndrome (surfactant deficiency syndrome)

Signs & Symptoms
Infant respiratory distress syndrome is characterized by diminished oxygen intake in the premature newborn. A clear membrane is found lining the alveolar (air cell) ducts in the lungs and is associated with reduced amounts of lung wetting agents or emulsifier (surfactant). The surfactant is a lipoprotein based on lecithin that stabilizes alveolar membranes. When this surfactant is missing, breathing is difficult and may lead to collapse of a lung. The affected infant must be placed on some type of ventilation, either mechanical or physical, in order to continue breathing.
Infant respiratory distress syndrome is caused by the absenteeism of a natural lung wetting agent (surfactant) in the immature lungs of infants. Since surfactant normally develops late in prenatal life it usually is not present in the very premature infant of about 26-36 weeks of gestational age. This can result in improper functioning of the alveoli (air cells) of the lungs causing breathing difficulties and collapsed lungs.
Surfactant protein-B (SP-B) deficiency is a rare type of infant respiratory distress syndrome caused by an abnormal pulmonary surfactant B gene. This type of infant respiratory distress syndrome follows autosomal recessive inheritance.
Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.

 Submit your Abstract in WCPNN 2019 Conference!!
Register as soon as Possible to avail early Bird registration on/before Dec 10, 2018

Friday, 2 November 2018

Pediatric Jaundice

Pediatric/Neonatal jaundice is a yellowish discoloration of the white part of the eyes and skin in a newborn baby due to high bilirubin levels. Other symptoms may include surplus sleepiness or poor feeding. Difficulties may include seizures, cerebral palsy, or kernicterus.
In many cases there is no specific underlying disorder (physiologic). In other cases it significances from red blood cell cessation, liver disease, infection, hypothyroidism, or metabolic complaints (pathologic). A bilirubin level more than 34 μmol/l (2 mg/dL) may be visible. Concerns, in otherwise healthy babies, occur when levels are greater than 308 μmol/L (18 mg/dL), jaundice is noticed in the first day of life, there is a quick rise in levels, jaundice lasts more than two weeks, or the baby appears unwell. In those with concerning findings further investigations to determine the underlying cause are recommended.
The need for treatment depends on bilirubin levels, the age of the child, and the underlying cause. Treatments may include more frequent feeding, phototherapy, or exchange transfusions.


In neonates, jaundice tends to progress because of two factors—the breakdown of fetal hemoglobin as it is swapped with adult hemoglobin and the relatively immature metabolic pathways of the liver, which are unable to conjugate and so defecate bilirubin as quickly as an mature. This causes an accumulation of bilirubin in the blood (hyperbilirubinemia), leading to the signs of jaundice.
If the neonatal jaundice does not resolve with simple phototherapy, other causes such as biliary atresia, Progressive familial intrahepatic cholestasis, bile duct paucity, Alagille syndrome, alpha 1-antitrypsin deficiency, and other pediatric liver diseases should be considered.

 Submit your Abstract in WCPNN 2019 Conference!!Abstract submission link:  submission.phpRegister as soon as Possible to avail early Bird registration on/before Dec 10, 2018Visit Website:

Tuesday, 30 October 2018

36th World Congress on Pediatric & Neonatal Nursing: Avail early Bird discount !!!

Conference Series LLC Ltd takes a lot of privilege in inviting the contributors across the globe to attend "36th World Congress on Pediatric and Neonatal nursing “to be held during March 1-2, 2019, Tokyo, Japan. Which includes prompt keynote presentations, Oral talks, Poster Presentations and Exhibitions.

Don't miss the chance to visit Japan !!
Register on/before 20 November 2018. 

Monday, 29 October 2018

#WCPNN 2019 emphasize on Pediatric Nursing Research

Pediatric Nursing Research is the restorative care of neonates and youngsters up to adolescence, as an edict in an in-patient hospital or day-clinic. Neonatal nurses are registered nurses who have some proficiency in working with these youthful, vulnerable patients. Neonatal nursing is a branch of health care that mostly centers in giving care and support for new-born babies who were born precipitately, or suffering from health problems such as birth defects, diseases, or heart deformities. Several neonatal nurses work in Neonatal Intensive Care Unit (NICU), providing very particular medicinal care to in danger infants.

                               Pediatric nurses are expected to have a fast flexibility and quick response on stressful situations to contain the life-threatening situations. Key features of pediatric emergency nursing include:

  •  Handling multidimensional trauma, injury or illness cases with equal levels of serenity     without letting the patients feel the urgency of the situation.
  •  Stabilizing patients with focused and wholesome care.
  •  Quickly diagnosing conditions and providing on-spot solutions.
  •  Administering the right medications to minimize pain.
  •  Keeping up with the fast-paced work environment by constantly upgrading skills and     knowledge.
  •  Being patient and caring for the families who accompany the little patients and working   on easing their mental trauma.

 Most importantly, not giving in to heartbreak and despair when some cases do not see improvement or success. Learning to control sentiments and moving on is the key to helping more and more patients in this work environment.

Sunday, 14 October 2018

Pediatric and Neonatal Nursing

About Conference

Conference Series LLC Ltd takes a lot of privilege in inviting the contributors across the globe to attend “World Congress on Pediatric and Neonatal nursing” to be held during March 1-2, 2019, Tokyo, Japan. Which includes prompt keynote presentations, Oral talks, Poster Presentations and Exhibitions.

Conference Series LLC Ltd through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. This conference brings together individuals who have an interest in Pediatric healthcare and practice, development and research.

This conference provides a several number of unexampled opportunities to guide your career. You can learn new passages to nursing practice, calibrate your intelligences and work with new technologies and gain ideas from experts at the forepart of Healthcare and Medicine.

Why Attend?

Advantage from updates and bits of knowledge on the most recent government Pediatrics procedure, and in addition recommendations for guaranteeing best practice and enhancing results.

Associate with more than 200 amazing representatives who are included in Pediatrics & Nursing, issue settle shared difficulties and gain from the broad experience of others.

Attend a variety of informative seminars, engaging interactive presentations, and keynote panel discussions with key policy makers and experts in Pediatrics and Neonatal nursing.      

Conference Highlights

Special Issues

  •  All accepted abstracts will be published in respective Supporting International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.